Christopher R. Fenimore, SVP Controller at REGENERON PHARMACEUTICALS, INC. (REGN), sold 3,860 shares at $844.09 ($3.3M) on 2023-12-21, disclosed to the SEC on 2023-12-26.
Scheduled sale ($3.3M) by SVP Controller under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $843.79 | 456 | $385K | 11.8% |
| 2 | $843.79 | 456 | $385K | 11.8% |
| 3 | $844.09 | 1,224 | $1.0M | 31.7% |
| 4 | $844.09 | 1,224 | $1.0M | 31.7% |
| 5 | $846.27 | 250 | $212K | 6.5% |
| 6 | $846.27 | 250 |
| $212K |
| 6.5% |
| Total | $844.30 avg | 3,860 | $3.3M | 100% |
| Filing → |
| REGN | SELL | 2023-12-29 | $4.2M | — | Filing → |
| REGN | SELL | 2023-03-27 | $3.5M | — | Filing → |
| REGN | SELL | 2022-10-07 | $1.4M | — | Filing → |